No material event; stock likely to trade on broader biotech sentiment and M&A speculation. Watch for any definitive acquisition agreement or pipeline update as the next catalyst.
Price Chart
Executive Summary
Instil Bio reported Q1 2026 GAAP EPS of -$0.62, a slight miss vs consensus -$0.59, but as a pre-revenue biotech the absolute variance is immaterial. Cash burn remains low at $1.6M during the quarter, with $74.7M cash expected to fund operations beyond 2027. The company is actively evaluating M&A opportunities but provided no specific updates.
Key Financial Metrics
Key Facts
- GAAP net loss per share of $0.62 for Q1 2026, compared to $4.32 in Q1 2025
- Cash, equivalents, restricted cash and marketable securities of $74.7M as of March 31, 2026
- R&D expenses fell to $0.7M from $5.4M; G&A to $5.3M from $9.1M year-over-year
- Restructuring charges of $1.0M, down from $16.1M in prior-year quarter
- Gain on contract termination of $1.6M offset operating loss
Financial Impact
EPS miss of $0.03 vs consensus; cash decreased $1.6M from year-end 2025
Risk Factors
- No revenue-generating products; reliance on M&A for growth
- Cash burn may accelerate if a transaction is pursued
- Dilution risk if stock is used to finance acquisitions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001789769-26-000044 |
| Document: til-20260515.htm | 0001789769-26-000044 |
| Document: 0001789769-26-000044-index-headers.html | 0001789769-26-000044 |
| Document: 0001789769-26-000044-index.html | 0001789769-26-000044 |
| Document: 0001789769-26-000044.txt | 0001789769-26-000044 |
| 8-K Data (Synthetic) | 0001789769-26-000044 |
Track record
8 reports on TIL
Filters
- Nov 16, 2026today 8-K Neutral 4/10 Entry $6.22 Now $5.75 −7.56% settles Dec 15
- Aug 13, 202613w ago Press Release Neutral 4/10 No price data
- Aug 13, 202613w ago 8-K Neutral 4/10 Entry $7.38 to $7.45 Now $5.75 −22.09% ▲ +0.95% +2.94% vs SPY
- May 15, 202626w ago 8-K Neutral 4/10 Viewing No price data
- May 15, 202626w ago Press Release Neutral 4/10 Entry $8.07 to $7.92 Now $5.75 −28.75% ▼ −1.86% −3.98% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 2/10 Entry $8.13 to $8.12 Now $5.75 −29.27% ▼ −0.12% −5.08% vs SPY
- Apr 3, 202632w ago 8-K Neutral 4/10 Entry $8.46 to $7.84 Now $5.75 −32.03% ▼ −7.33% −16.31% vs SPY
- Mar 27, 202633w ago Press Release Mixed 5/10 Entry $7.79 to $8.13 Now $5.75 −26.19% ▲ +4.36% −8.38% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers